Drug and Medical Device Safety: Product Liability (Podcast 3 of 4)

The Global Pharmaceutical Center presents a series of four podcasts that delve deep into issues from Progressions 2007, The Ernst & Young Global Pharmaceutical Report. By registering for this series, you'll have access to each podcast as it is released.

Podcast 3 - Product Liability

When the quality of a pharmaceutical product is compromised, the financial risks that arise --through product liability litigation and product recalls-- range from mild to catastrophic. How are companies using risk management strategy to limit liability and exposure? What should pharma CEOs/CFOs be thinking about in order to mitigate the financial risks? Hear a discussion on the financial risks and other issues posed by product safety -- in particular, how executives across the enterprise should be addressing product liability and recalls.

Podcast 1 - Product Safety Compliance 
Podcast 2 - Data Analytics
Podcast 4 - Leveraging Customs for Patient Safety Coming October 15, 2007

Each podcast is hosted by Chris Gray, Managing Editor of Progressions 2007, and features candid interviews with industry professionals who share their insight and opinions with listeners.

More in Biotechnology & Pharmaceutical

image

Released on:
Monday, October 01, 2007

(n/a
n/a your local time)

Duration: 22 minutes

Note: the webcast technology is not compatible with the browser you are using. Use Internet Explorer or Firefox.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.